Lilly installing new labs, offices, manufacturing lines in $90M project
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
Indiana, one of the largest per-capita energy consumers in the nation, ranks 40th among states for energy efficiency, according to the American Council for an Energy-Efficient Economy.
The society, which has lost more than half its membership in the past two decades, is looking for a new home for many historical items, including a 1910 Waltham Gothic revival grandfather hall clock, a painting by Hoosier artist T.C. Steele and historic medical treatment books and documents.
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
A few influential “serial entrepreneurs” in Indiana universities feel an itch to turn their discoveries into products and companies, over and over again.
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
The Bloomington-based maker of medical devices will use the building at 1102 Indiana Ave. to do research on cell and gene therapy in collaboration with the Indiana University School of Medicine and other organizations.
The acquisitions are the first for IEA since it went public this spring, and signal that the company is pushing hard for more growth in the booming renewable energy sector.
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
Jim Litten started with F.C. Tucker in 1972, and today he leads the state's largest independent real estate firm, with 40 offices, 1,500 agents and 400 employees.
Seema Verma, administrator for the Centers for Medicare and Medicaid Services and former health consultant to Mitch Daniels and Mike Pence, visited Indianapolis on Monday to drum up excitement for the program, which now covers about 20 million Americans.
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
The deal represents a huge breakthrough for tiny Endocyte, which has about 90 employees in Indiana but has not yet launched a single product.
The standalone, two-story facility is expected to offer a wide array of inpatient and outpatient services, including addiction treatment, counseling and psychiatric intensive care.
The researchers looked to the oceans to see how they could develop surgical materials from sea creatures such as mussels, barnacles and oysters, which can bond to wet rocks with protein-based adhesives.
State regulators approved a 30 percent increase from Citizens in 2016. The utility now says it needs to raise rates to continue funding its massive DigIndy tunnel system project.
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
The state of New York is blaming 49 industrial sites in Indiana—and hundreds of other sites across the Midwest—for causing it to miss ozone air-pollution requirements.